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Abstract 
A heterologous immunoassay has been developed for the determination of Ciprofloxacin (CPFX) residues in milk. 
For this reason, carbodiimide active ester method was employed to synthesize the artificial antigen of CPFX-BSA, 
and mixed anhydride reaction was used to prepare the coating antigen of CPFX-OVA to pursue the heterologous 
sensitivity. Based on the square matrix titration, an icELISA method was developed for the quantitative detection of 
CPFX in cattle milk. The dynamic range was from 0.036 to 92.5 ng/mL, with LOD and IC50 value of 0.019 ng/mL 
and 1.8 ng/mL, respectively. Except for a high cross-reactivity (89.7%) to Enrofloxacin, negligible cross-reactivity to 
the other compounds was observed. After optimization, 0.03 mol/L of HCl, or 10% of methanol was used in the assay 
buffer. 20-fold dilution in cattle milk gave an inhibition curve almost the same as that in PBS buffer. The regression 
equation for this assay was y = 0.9036 x + 1.4574, with a correlation coefficient (R2) of 0.9844. The results suggest 
the veracity of the heterologous immunoassay for detecting CPFX residue in milk. 
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1. Introduction  
Fluoroquinolones are gaining widespread acceptance in veterinary medicine because of its wide 
spectrum of activity and favorable pharmacokinetic behavior [1]. Generally, fluoroquinolones are 
characterized by excellent tissue penetration, high bioavailability and long terminal half-life, in which 
enrofloxacin is used in beef breed cattle with respiratory and digestive diseases and in dairy cattle 
suffering from acute E.coli mastitis. However, enrofloxacin residue may persist in animal or human body, 
resulting in the development of drug-resistant bacterial strains or allergies [2]. Therefore, routine analysis 
and residual detection are required, and several immunoassay techniques have thus been developed for 
the determination of enrofloxacin [3-8]. 
Ciprofloxacin (CPFX) is a major metabolite of enrofloxacin, and is also one of the most widely used 
FQs for the treatment of urinary tract infections, respiratory tract infections and chronic bacterial 
prostatitis [9]. On the other hand, the CPFX residues in livestock products may cause serious public 
health problems. An EU Regulation has set an MRL of 30 ȝg/kg for the sum of CPFX and enrofloxacin in 
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edible animal tissues [10]. Therefore, rapid and simple detection techniques are required to determine the 
CPFX residue level in food products. 
In this study, we have aimed to prepare the artificial antigen of CPFX and produce anti-CPFX 
polyclonal antibody (pAb). On the basis, we developed a quantitative enzyme immunoassay to detect the 
CPFX residue in cattle milk. The analytical performance of the developed method is reported here and its 
applicability to the analysis of CPFX residue is discussed. 
2. Materials and Methods 
2.1 Materials and reagents 
Ciprofloxacin, Enrofloxacin, Sarafloxacin, Ofloxacin, Norfloxacin, and Danofloxacin were provided by 
Sigma (St. Louis, MO). BSA, OVA and GaRIgG-HRP were purchased from Sino-American 
Biotechnology Company (Shanghai, China). FCA, FIA and EDC were obtained from Pierce. NHS was 
from Japan, MSDS available. O-(Carboxymethyl) hydroxylamine hemihydrochloride, Succinic 
anhydride, were supplied by Sigma while Dialysis bag (8000-14000 Da) was from Solarbio Company. 
TMB, phenacetin, urea peroxide were obtained from Sigma Company. All other solvents and reagents 
were of analytical grade or higher, unless otherwise stated. A spectrophotometric microtitre reader, 
MULTISKAN MK3 (Thermo company, USA) was used for absorbance measurements.  
2.2 Synthesis of immunogen and coating antigen  
The immunogen of CPFX-BSA was prepared by carbodiimide active ester method as a modified 
previous paper [11]. A total of 7.72 mg of CPFX, 40 mg of EDC, and 10 mg of NHS were added to 0.5 mL 
DMF in order. The mixture solution was incubated for 24 h at room temperature in dark. Then 2.5 mL of 
PBS (0.01 mol/L, pH 7.4) with 64 mg BSA was added slowly to the mixture solution with stirring, 
followed by 4-h incubation at room temperature. Finally, the reaction mixture was dialyzed under stirring 
against PBS for 6 d with repeated changes of the PBS solution to remove the unconjugated hapten. The 
solution was stored at -20ć. A CPFX-OVA conjugate was prepared based on the mixed anhydride 
reaction described by Bucknall et al. [12]. 
2.3 Immunization 
Three Female New Zealand white rabbits were subcutaneously immunized at four sites in the back with 
CPFX-BSA conjugate. FCA was employed in the first immunization and FIA was used in the subsequent 
boost injections. Rabbits were immunized every 28 days with 500 ȝg of immunogen, and blood samples 
were taken for ELISA identification from the marginal vein of the ear 10 days after each immunization. 
Ten days after the final boost, all rabbits were exsanguinated by heart puncture and the serum was purified 
with saturated ammonium sulfate (SAS) precipitation method. 
2.4 Buffers 
The ELISA buffers used were as follows: phosphate buffered saline (PBS) consisted of NaCl (137 
mM), Na2HPO4.12H2O (10 mM), KCl (2.68 mM) and KH2PO4 (1.47 mM), pH 7.4; Carbonate buffer saline 
(CBS) contained Na2CO3 (15 mM), NaHCO3 (35 mM), pH 9.6; Washing buffer consisted of PBS 
containing 0.05% Tween-20; Blocking buffer contained BSA (1%, w/v) in PBS buffer. The stopping 
solution was 2 M H2SO4. 
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2.5 Development of ELISA standard curves 
Indirect and indirect competitive ELISA procedures were performed according to Jiang et al. [13]. The 
antibody titer was defined as the reciprocal of the dilution that resulted in an absorbance value that was 
twice that of the background. With the icELISA format, analytes that do not react with the antibody would 
produce absorbance near 100%; conversely, analytes that do react with the antibody would decrease in 
percentage of absorbance. All samples were run in triplicates, and competition curves were obtained by 
plotting absorbance against the logarithm of analyte concentrations, which were fitted to a four-parameter 
logistic equation. 
2.6 Characteristics and optimization of icELISA 
Sensitivity was evaluated according to the inhibition rate, and the data were calculated using the IC50 
values, which represented the concentration of CPFX that produced 50% inhibition of antiserum binding 
to the hapten conjugate. The detection of limit (LOD) was defined as the lowest concentration that 
exhibits a signal of 15% inhibition [14]. The dynamic range for the icELISA was calculated as the 
concentration of the analyte providing a 20–80% inhibition rate (IC20–IC80 values) of the maximum signal. 
Specificity was defined as the ability of structurally related chemicals to bind to the specific antibody. 
The cross-reactivity was calculated as: (IC50 of CPFX)/ (IC50 of competitors) ×100. The lower the CR is, 
the higher the specificity of CPFX pAb is. 
CPFX stock solution was prepared in PBS containing different concentrations of HCl or methanol. To 
optimize the schedule, the standards were prepared using 0.01, 0.02, 0.03, 0.04, and 0.05 mM of HCl, or 
5%, 10%, 20%, 30%, and 40% of methanol. The effects on icELISA standard curves were evaluated by 
Amax and IC50 values. 
2.7 Matrix effects in authentic cattle  milk samples 
A total of 2 mL of milk samples were centrifuged at 4  ć with a speed of 10000 rpm for 30 min, and 
the floated fat was discarded. In order to reduce the backgrounds and assess residual matrix interference, 
extracted milk samples were diluted in PBS (total 2, 5, 10 and 20 –fold dilution) before they were applied 
to the microtiter plate. Typical experimental response curves were plotted by the absorbance values, 
against the concentration of CPFX, where B is the absorbance of the well containing CPFX and B0 is the 
absorbance of the well without competitor. Diluted curves were compared with that generated from the 
PBS buffer to determine the appropriate milk dilution. 
Under the optimal dilution programme, recovery studies were determined by spiking a pool of 
negative milk samples with different CPFX concentrations based on the icELISA calibration curve.  The 
concentration measured and concentration fortified was compared to validate the effectiveness of the 
developed immunoassay. 
3. Results And Discussions 
3.1 Immunogen and coating antigen Synthesis     
CPFX with a molecular weight of 331.4, is too small to be immunogenic, and must be conjugated to a 
carrier protein before immunization to elicit an immune response. Among protein carriers, BSA and OVA 
are two of the most preferred ones which were used for synthesizing immunogen and coating antigen 
respectively. The synthetic pathways for complete antigens and coating antigen are presented in Fig. 1 
and 2. It is said that heterology is a proper strategy for the improvement of assay sensitivity in 
immunoassays [15], which has also been demonstrated in our following experimental data. Heterologous 
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system in competitive ELISA is termed to indicate the differences in hapten structure, linker attachment 
site, or bridge character, which usually results in weaker recognition of antibodies to coating antigen 
compared to target compound. When designing the antigen, we attempted to exploit the previously 
described principles. Carbodiimide active ester method were employed in immunogen synthesis while 
mixed anhydride reaction was used for coating antigen of CPFX-OVA, which pursued the difference in 
bridge length. 
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Fig. 1. Synthesis procedure for CPFX immunogen through carbodiimide active ester method. 
N
F
O
COOH
N
HN
N
F
O
N
HN
COOCOO(CH3)3
(CH3)3COOCCl
NH2-OVA
N
F
O
N
HN
COOCONH-OVA
 
Fig. 2. Synthesis procedure for CPFX coating antigen through the mixed-anhydride technique. 
3.2 Establishment of the indirect competitive ELISA 
Three rabbits were immunized with the CPFX-BSA conjugate following the standard protocols 
described above, while CPFX-OVA were coated onto ELISA plates to determine the titer and inhibition 
level of antisera. Checkerboard titrations were performed, taking into account the optimal dilutions. The 
optimal reagent concentrations were determined when the maximum absorbance (Amax) was around 1.0, 
and the dose-response curve of inhibition ratio versus the logarithm of CPFX concentration pursued the 
lowest IC50 values. From the checkerboard assays (data not shown), four representative standard inhibition 
curves are shown in Fig. 3. Based on the results, a competitive curve was obtained with the icELISA 
format (Fig. 4). As can be seen, the optimum concentration of coating antigen was 2 ȝg/mL and pAb was 
1:5000 dilutions. This assay allowed the detection of CPFX (20-80% inhibition of color development) 
from 0.036 to 92.5 ng/mL, with an IC50 value of 1.8 ng/mL. The limit of detection (LOD) of the assay was 
0.019 ng/mL. 
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Fig. 3. Determining optimal parameter of coating antigen and CPFX pAb by indirect competitive ELISA. (A) coating antigen 2 
ȝg/mL, pAb 1:5000; (B) coating antigen 2 ȝg/mL, pAb 1:10000; (C) coating antigen 1 ȝg/mL, pAb 1:5000; (D) coating antigen 
1ȝg/mL, pAb 1:10000. 
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Fig. 4. Optimized standard heterologous icELISA inhibition curve for CPFX. Data were obtained by averaging three independent 
curves, each run in triplicate. CPFX-OVA (2 ȝg/mL) as coating antigen was prepared in CBS (pH 9.6), purified anti-serum produced 
by CPFX-BSA as immunogen was diluted 1:5000 in PBS (pH 7.4), CPFX was prepared in PBS, containing 10% methanol, GaRIgG-
HRP was diluted 1:1000 in incubation buffer. The regression curve was y=17.614x+45.369, R2=0.9812. 
3.3 Specificity 
Specificity is inherent to all immunoassays, which was evaluated by determination of the cross-
reactivity based on the IC50 values. The cross-reactivity rate for each compound is presented in Table 1. 
Of all the cross-reacting analogues, this assay exhibited a high cross-reactivity (89.7%) to Enrofloxacin, 
but negligible cross-reactivity to the other compounds tested. It proves that the immunoassay is highly 
specific for CPFX. 
Table 1. Cross-reactivities of related functional analogues in the CPFX immunoassay 
analogues IC50 ( ng/mL ) CR (%) 
Ciprofloxacin 1.8 100 
Enrofloxacin 2.01 89.7 
Sarafloxacin ˚3600 ˘0.05 
1834   Jiang Jinqing et al. /  Physics Procedia  25 ( 2012 )  1829 – 1836 
 
Ofloxacin ˚3600 ˘0.05 
Norfloxacin ˚18000 ˘0.01 
Danofloxacin ˚18000 ˘0.01 
3.4 Preparation of CPFX stock solution 
CPFX is difficultly dissolved in water; therefore suitable hydrotropy solvents are needed. HCl or 
methanol is two commonly used agents for this, which are also applied in this study. The effects of these 
parameters were estimated by running standard curves under various conditions. The maximum 
absorbance (Amax, the absorbance value at zero concentration of CPFX) and half-maximum inhibition 
concentration (IC50, the value represents the concentration of CPFX that produce 50% inhibition of 
antibody binding to the hapten conjugate) were calculated, and the results are shown in Fig. 5. Based on 
the results, 0.03 mM HCl or 10% methanol is suitable for this study. 
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Fig. 5. Effects of HCl in assay buffer (A) and methanol concentrations (B). Each solid symbol represents the mean of three 
replicates. Insets indicate the fluctuation of IC50 values. 
3.5 Matrixl effects 
It has been known that various substances existing in complex matrixes can affect antigen-antibody 
interaction. Dietary components, higher ionic strengths and the pH parameters also strongly suppress the 
IC50 value and the maximum absorbance. A comparison between calibration plots for CPFX prepared in 
PBS and those prepared in different dilutions of milk gave clear evidence of matrix effect (Fig. 6). It was 
found that the dilution 1:20 in cattle milk gives the inhibition curve almost the same as that of PBS buffer. 
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Fig. 6. CPFX standard curves in the diluted milk samples.Ƶ in the PBS buffer, Ʒ2-fold dilution, ƹ5-fold dilution, ƾ
10-fold dilutionƽ20-fold dilution. Each point represents the average of three separate assays in triplicate. 
3.6 Validation of the heterologous icELISA 
Under the 20-fold dilution, the accuracy of the analysis was studied by the comparative detection of 
fortified CPFX in milk samples at different concentrations, and the measurement correlations were shown 
in Fig. 7. We can find that the data spots were nearly distributed on both sides of the trendline, the 
regression equation for this assay was y = 0.9036 x + 1.4574, with a correlation coefficient (R2) of 0.9844. 
This indicates that an excellent correlation was found, and the results also suggest the veracity of the 
icELISA method for detecting CPFX residue in milk. 
y = 0.9036x + 1.4574
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Fig. 7. Correlations between concentration spiked and concentration determined in cattle milk samples fortified with CPFX. 
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